BPG is committed to discovery and dissemination of knowledge
Observational Study
©Author(s) (or their employer(s)) 2026.
World J Clin Pediatr. Mar 9, 2026; 15(1): 111388
Published online Mar 9, 2026. doi: 10.5409/wjcp.v15.i1.111388
Table 1 Demographic and clinical characteristics of participants, n (%)
Variable
Category
Experimental group (n = 300)
Control group (n = 300)
χ2
P value
Age (years)3, 4135 (45.0)106 (35.3)6.720.034
4, 568 (22.7)90 (30.0)
5, 697 (32.3)104 (34.7)
GenderMale187 (62.3)200 (66.7)0.810.369
Female113 (37.7)100 (33.3)
ResidenceRural164 (54.7)192 (64.0)4.580.032
Urban136 (45.3)108 (36.0)
IV siteCephalic vein5 (1.7)21 (7.0)12.450.002
Metacarpal vein259 (86.3)266 (88.7)
Median vein36 (12.0)13 (4.3)
IV cannula size22 G63 (21.0)98 (32.7)7.880.005
24 G237 (79.0)202 (67.3)
Table 2 Post-test pain levels (Wong-Baker FACES Pain Rating Scale) by group, n (%)
Pain level (Wong-Baker FACES Pain Rating Scale)
Experimental group (n = 300)
Control group (n = 300)
P value
No hurt (0)20 (6.67)0 (0.00)< 0.001
Hurts little bit (1)114 (38.00)0 (0.00)
Hurts little more (2)151 (50.33)0 (0.00)
Hurts even more (3)15 (5.00)0 (0.00)
Hurts whole lot (4)0 (0.00)167 (55.66)
Hurts worst (5)0 (0.00)133 (44.33)
Table 3 Predictors of severe pain
Variable
Category
B
SE
Odds ratio (95%CI)
P value
GroupControl vs experimental5.980.58396.4 (125.9-1247.7)< 0.001
Age (years)3, 4 (refence: 5, 6)0.640.281.89 (1.10-3.25)0.021
GenderMale vs female0.290.261.34 (0.80-2.23)0.263
ResidenceRural vs urban0.410.251.51 (0.93-2.45)0.098
Intravenous siteCephalic vs metacarpal1.880.586.54 (2.08-20.54)0.001
Median vs metacarpal)0.720.352.06 (1.05-4.06)0.036
Cannula size22 G vs 24 G0.860.262.36 (1.39-4.02)0.002
Table 4 Comparison of post-test pain scores
Group
Mean (Wong-Baker FACES Pain Rating Scale)
SD
Mean difference
t value
P value
Experimental (n = 300)3.071.3905.7358.56< 0.001
Control (n = 300)8.801.007
Table 5 Predictors of high anxiety
Variable
Category
B
SE
Odds ratio (95%CI)
P value
GroupControl vs experimental)4.860.55129.2 (44.7-373.6)< 0.001
Age (years)3, 4 (refence: 5, 6)0.720.302.06 (1.14-3.72)0.017
GenderMale vs female0.330.271.39 (0.81-2.39)0.232
ResidenceRural vs urban0.480.261.62 (0.97-2.71)0.066
Intravenous siteCephalic vs metacarpal1.550.534.72 (1.66-13.42)0.004
Median vs metacarpal0.610.321.84 (0.98-3.43)0.057
Cannula size22 G vs 24 G0.910.272.48 (1.46-4.21)0.001
Table 6 Comparison of post-test anxiety scores
Group
Mean (Visual Analogue Anxiety Scale)
SD
Mean difference
t value
P value
Experimental (n = 300)5.851.5603.5435.55< 0.00001
Control (n = 300)9.390.730
Table 7 Correlation between pain and anxiety scores by group
Group
Pain, mean (SD)
Anxiety, mean (SD)
r value
P value
Experimental (n = 300)3.07 (1.39)5.85 (1.56)0.67< 0.05
Control (n = 300)8.80 (1.01)9.39 (0.73)0.66< 0.05